SERS-based detection of 5-<i>S</i>-cysteinyl-dopamine as a novel biomarker of Parkinson's disease in artificial biofluids
Isidro Badillo‐Ramírez, Bruno Landeros‐Rivera, José M. Sániger, Jürgen Popp, Dana Cialla‐May
Abstract
M. In conclusion, we show that CDA can be suitably detected by means of label-free SERS spectroscopy, which can significantly improve its sensitive detection for further analytical studies as a novel biomarker and further clinical diagnosis in PD patients.
Topics & Concepts
DopamineBiomarkerParkinson's diseaseDiseaseNeuroscienceMedicineComputational biologyBiologyInternal medicineBiochemistryElectrochemical sensors and biosensorsNeuroscience and Neural EngineeringElectrochemical Analysis and Applications